Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions and spanning the data center core to network edge in the United States, Argentina, China, India, Israel, Japa…
FAIL · Does not pass the screen
225.41 USD
At the last full screen 2026-09-08
Screened 2026-09-08 · the tape above runs as of 23:00 UTC · 17 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
Marvell Technology holds its Markup at $225.41. Consolidating, no directional conviction, held for 35 days.
As held on the ledger · 2026-09-08
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 35 days
Price at the screen
$225.41
Valuation
74.64 trailing · 33.54 forward price to earnings
Values screen
FAIL· score 10.0
Beta
2.25
The Workings
Five Screens, Shown in Full
Does not pass. Revenue purity 21.0%
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
21.50%
Below 33%
Interest-bearing debt is just 21.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
11.84%
Below 33%
Cash held in interest-bearing accounts and securities is 11.8% of assets, under the one-third limit.
Pass
Receivables
9.81%
Below 49%
Money owed to the company is 9.8% of assets, under the 49% limit.
Pass
Revenue purity
21.03%
Below 5%
21.0% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades above our $170.40 fair value estimate, 36.50% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. The price runs 24.4% above the base estimate.
Third-party analyst targets: 41 covering, consensus Strong Buy. The average target sits +26% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Marvell's High-Priced Chips in a Cyclical Storm
Consider the world's data centers, the beating hearts of the internet, and Marvell Technology provides the semiconductors that power them. Yet, the chip industry is famously cyclical, and Marvell's current price of $251.01 is riding high on peak earnings. It's a warning sign, not a value play. Why it stands out. Despite these headwinds, Marvell boasts a forward P/E of 40.2x and a robust revenue growth of 28%. However, with a profit margin of 29% and a ROE of 16%, these numbers are亮眼 but not exceptional, especially when the market is currently pricing Marvell at a significant premium to our fair value estimate of $150.15, which represents a 40% discount to its current price.
Risk sits around the ethical performance of Marvell, which has failed our ethical screen, largely due to a revenue purity score of only 21.0%. The consensus rating is strong buy from 40 analysts, with a median target of $248, yet this is a market opinion, not a guarantee. In the cyclical semiconductor industry, the glimmer of high earnings can be a mirage, masking the underlying volatility that investors should be wary of. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MRVL trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-27Markup$251.01+0.0%Entry 12
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-26Markup$251.01+0.0%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-25Markup$251.01+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Markup$251.01+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-23Markup$251.01+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-22Markup$251.01+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-21Markup$251.01+19.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 19.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-20Markup$211.02+0.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-06Markup$211.02-19.9%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 19.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150.
2026-07-18Markup$263.47+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 116% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 272%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (40 analysts) rates it strong buy, with a mean price target of $150.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
